Cargando…

Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch’s postulates

Inflammatory bowel disease (IBD) is a chronic non-specific inflammatory disease that occurs in the intestinal tract. It is mainly divided into two subtypes, i.e., the Crohn’s disease (CD) and ulcerative colitis (UC). At present, its pathogenesis has not been fully elucidated, but it has been general...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, HanZheng, Zhang, WenHui, Cheng, Die, You, LiuPing, Huang, YueNan, Lu, YanJie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684636/
https://www.ncbi.nlm.nih.gov/pubmed/36438062
http://dx.doi.org/10.3389/fmed.2022.1023896
_version_ 1784835333618139136
author Zhao, HanZheng
Zhang, WenHui
Cheng, Die
You, LiuPing
Huang, YueNan
Lu, YanJie
author_facet Zhao, HanZheng
Zhang, WenHui
Cheng, Die
You, LiuPing
Huang, YueNan
Lu, YanJie
author_sort Zhao, HanZheng
collection PubMed
description Inflammatory bowel disease (IBD) is a chronic non-specific inflammatory disease that occurs in the intestinal tract. It is mainly divided into two subtypes, i.e., the Crohn’s disease (CD) and ulcerative colitis (UC). At present, its pathogenesis has not been fully elucidated, but it has been generally believed that the environment, immune disorders, genetic susceptibility, and intestinal microbes are the main factors for the disease pathogenesis. With the development of the sequencing technology, microbial factors have received more and more attention. The gut microbiota is in a state of precise balance with the host, in which the host immune system is tolerant to immunogenic antigens produced by gut commensal microbes. In IBD patients, changes in the balance between pathogenic microorganisms and commensal microbes lead to changes in the composition and diversity of gut microbes, and the balance between microorganisms and the host would be disrupted. This new state is defined as dysbiosis. It has been confirmed, in both clinical and experimental settings, that dysbiosis plays an important role in the occurrence and development of IBD, but the causal relationship between dysbiosis and inflammation has not been elucidated. On the other hand, as a classic research method for pathogen identification, the Koch’s postulates sets the standard for verifying the role of pathogens in disease. With the further acknowledgment of the disease pathogenesis, it is realized that the traditional Koch’s postulates is not applicable to the etiology research (determination) of infectious diseases. Thus, many researchers have carried out more comprehensive and complex elaboration of Koch’s postulates to help people better understand and explain disease pathogenesis through the improved Koch’s postulates. Therefore, focusing on the new perspective of the improved Koch’s postulates is of great significance for deeply understanding the relationship between dysbiosis and IBD. This article has reviewed the studies on dysbiosis in IBD, the use of microbial agents in the treatment of IBD, and their relationship to the modified Koch’s postulates.
format Online
Article
Text
id pubmed-9684636
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96846362022-11-25 Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch’s postulates Zhao, HanZheng Zhang, WenHui Cheng, Die You, LiuPing Huang, YueNan Lu, YanJie Front Med (Lausanne) Medicine Inflammatory bowel disease (IBD) is a chronic non-specific inflammatory disease that occurs in the intestinal tract. It is mainly divided into two subtypes, i.e., the Crohn’s disease (CD) and ulcerative colitis (UC). At present, its pathogenesis has not been fully elucidated, but it has been generally believed that the environment, immune disorders, genetic susceptibility, and intestinal microbes are the main factors for the disease pathogenesis. With the development of the sequencing technology, microbial factors have received more and more attention. The gut microbiota is in a state of precise balance with the host, in which the host immune system is tolerant to immunogenic antigens produced by gut commensal microbes. In IBD patients, changes in the balance between pathogenic microorganisms and commensal microbes lead to changes in the composition and diversity of gut microbes, and the balance between microorganisms and the host would be disrupted. This new state is defined as dysbiosis. It has been confirmed, in both clinical and experimental settings, that dysbiosis plays an important role in the occurrence and development of IBD, but the causal relationship between dysbiosis and inflammation has not been elucidated. On the other hand, as a classic research method for pathogen identification, the Koch’s postulates sets the standard for verifying the role of pathogens in disease. With the further acknowledgment of the disease pathogenesis, it is realized that the traditional Koch’s postulates is not applicable to the etiology research (determination) of infectious diseases. Thus, many researchers have carried out more comprehensive and complex elaboration of Koch’s postulates to help people better understand and explain disease pathogenesis through the improved Koch’s postulates. Therefore, focusing on the new perspective of the improved Koch’s postulates is of great significance for deeply understanding the relationship between dysbiosis and IBD. This article has reviewed the studies on dysbiosis in IBD, the use of microbial agents in the treatment of IBD, and their relationship to the modified Koch’s postulates. Frontiers Media S.A. 2022-11-10 /pmc/articles/PMC9684636/ /pubmed/36438062 http://dx.doi.org/10.3389/fmed.2022.1023896 Text en Copyright © 2022 Zhao, Zhang, Cheng, You, Huang and Lu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Zhao, HanZheng
Zhang, WenHui
Cheng, Die
You, LiuPing
Huang, YueNan
Lu, YanJie
Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch’s postulates
title Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch’s postulates
title_full Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch’s postulates
title_fullStr Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch’s postulates
title_full_unstemmed Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch’s postulates
title_short Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch’s postulates
title_sort investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified koch’s postulates
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684636/
https://www.ncbi.nlm.nih.gov/pubmed/36438062
http://dx.doi.org/10.3389/fmed.2022.1023896
work_keys_str_mv AT zhaohanzheng investigatingdysbiosisandmicrobialtreatmentstrategiesininflammatoryboweldiseasebasedontwomodifiedkochspostulates
AT zhangwenhui investigatingdysbiosisandmicrobialtreatmentstrategiesininflammatoryboweldiseasebasedontwomodifiedkochspostulates
AT chengdie investigatingdysbiosisandmicrobialtreatmentstrategiesininflammatoryboweldiseasebasedontwomodifiedkochspostulates
AT youliuping investigatingdysbiosisandmicrobialtreatmentstrategiesininflammatoryboweldiseasebasedontwomodifiedkochspostulates
AT huangyuenan investigatingdysbiosisandmicrobialtreatmentstrategiesininflammatoryboweldiseasebasedontwomodifiedkochspostulates
AT luyanjie investigatingdysbiosisandmicrobialtreatmentstrategiesininflammatoryboweldiseasebasedontwomodifiedkochspostulates